These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 25620535

  • 1. Etifoxine versus alprazolam for the treatment of adjustment disorder with anxiety: a randomized controlled trial.
    Stein DJ.
    Adv Ther; 2015 Jan; 32(1):57-68. PubMed ID: 25620535
    [Abstract] [Full Text] [Related]

  • 2. Efficacy of etifoxine compared to lorazepam monotherapy in the treatment of patients with adjustment disorders with anxiety: a double-blind controlled study in general practice.
    Nguyen N, Fakra E, Pradel V, Jouve E, Alquier C, Le Guern ME, Micallef J, Blin O.
    Hum Psychopharmacol; 2006 Apr; 21(3):139-49. PubMed ID: 16625522
    [Abstract] [Full Text] [Related]

  • 3. Pregabalin for treatment of generalized anxiety disorder: a 4-week, multicenter, double-blind, placebo-controlled trial of pregabalin and alprazolam.
    Rickels K, Pollack MH, Feltner DE, Lydiard RB, Zimbroff DL, Bielski RJ, Tobias K, Brock JD, Zornberg GL, Pande AC.
    Arch Gen Psychiatry; 2005 Sep; 62(9):1022-30. PubMed ID: 16143734
    [Abstract] [Full Text] [Related]

  • 4. Etifoxine is non-inferior than clonazepam for reduction of anxiety symptoms in the treatment of anxiety disorders: a randomized, double blind, non-inferiority trial.
    Vicente B, Saldivia S, Hormazabal N, Bustos C, Rubí P.
    Psychopharmacology (Berl); 2020 Nov; 237(11):3357-3367. PubMed ID: 33009629
    [Abstract] [Full Text] [Related]

  • 5. [Treatment of adjustment disorder with anxiety: efficacy and tolerance of etifoxine in a double-blind controlled study].
    Servant D, Graziani PL, Moyse D, Parquet PJ.
    Encephale; 1998 Nov; 24(6):569-74. PubMed ID: 9949940
    [Abstract] [Full Text] [Related]

  • 6. Novel Augmentation Strategies in Major Depression.
    Martiny K.
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
    [Abstract] [Full Text] [Related]

  • 7. [Evaluation of the therapeutic efficacy and safety of the selective anxiolytic afobazole in generalized anxiety disorder and adjustment disorders: Results of a multicenter randomized comparative study of diazepam].
    Syunyakov TS, Neznamov GG.
    Ter Arkh; 2016 Apr; 88(8):73-86. PubMed ID: 27636931
    [Abstract] [Full Text] [Related]

  • 8. Deramciclane in the treatment of generalized anxiety disorder: a placebo-controlled, double-blind, dose-finding study.
    Naukkarinen H, Raassina R, Penttinen J, Ahokas A, Jokinen R, Koponen H, Lepola U, Kanerva H, Lehtonen L, Pohjalainen T, Partanen A, Mäki-Ikola O, Rouru J, Deramciclane Dose-Finding Study Group.
    Eur Neuropsychopharmacol; 2005 Dec; 15(6):617-23. PubMed ID: 15949921
    [Abstract] [Full Text] [Related]

  • 9. Desvenlafaxine 50 and 100 mg/d in the treatment of major depressive disorder: an 8-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group trial and a post hoc pooled analysis of three studies.
    Tourian KA, Padmanabhan SK, Groark J, Brisard C, Farrington D.
    Clin Ther; 2009 Jun; 31 Pt 1():1405-23. PubMed ID: 19698901
    [Abstract] [Full Text] [Related]

  • 10. Efficacy and safety of hydroxyzine in the treatment of generalized anxiety disorder: a 3-month double-blind study.
    Llorca PM, Spadone C, Sol O, Danniau A, Bougerol T, Corruble E, Faruch M, Macher JP, Sermet E, Servant D.
    J Clin Psychiatry; 2002 Nov; 63(11):1020-7. PubMed ID: 12444816
    [Abstract] [Full Text] [Related]

  • 11. Opipramol for the treatment of generalized anxiety disorder: a placebo-controlled trial including an alprazolam-treated group.
    Möller HJ, Volz HP, Reimann IW, Stoll KD.
    J Clin Psychopharmacol; 2001 Feb; 21(1):59-65. PubMed ID: 11199949
    [Abstract] [Full Text] [Related]

  • 12. Fluvoxamine CR in the long-term treatment of social anxiety disorder: the 12- to 24-week extension phase of a multicentre, randomized, placebo-controlled trial.
    Stein DJ, Westenberg HG, Yang H, Li D, Barbato LM.
    Int J Neuropsychopharmacol; 2003 Dec; 6(4):317-23. PubMed ID: 14604447
    [Abstract] [Full Text] [Related]

  • 13. Switching from long-term benzodiazepine therapy to pregabalin in patients with generalized anxiety disorder: a double-blind, placebo-controlled trial.
    Hadley SJ, Mandel FS, Schweizer E.
    J Psychopharmacol; 2012 Apr; 26(4):461-70. PubMed ID: 21693549
    [Abstract] [Full Text] [Related]

  • 14. A double-blind evaluation of the safety and efficacy of abecarnil, alprazolam, and placebo in outpatients with generalized anxiety disorder. Abecarnil Work Group.
    Lydiard RB, Ballenger JC, Rickels K.
    J Clin Psychiatry; 1997 Apr; 58 Suppl 11():11-8. PubMed ID: 9363043
    [Abstract] [Full Text] [Related]

  • 15. Local and global effects of sedation in resting-state fMRI: a randomized, placebo-controlled comparison between etifoxine and alprazolam.
    Wein S, Riebel M, Seidel P, Brunner LM, Wagner V, Nothdurfter C, Rupprecht R, Schwarzbach JV.
    Neuropsychopharmacology; 2024 Oct; 49(11):1738-1748. PubMed ID: 38822128
    [Abstract] [Full Text] [Related]

  • 16. Alprazolam: an antidepressant? Alprazolam, desipramine, and an alprazolam-desipramine combination in the treatment of adult depressed outpatients.
    Fawcett J, Edwards JH, Kravitz HM, Jeffriess H.
    J Clin Psychopharmacol; 1987 Oct; 7(5):295-310. PubMed ID: 3316312
    [Abstract] [Full Text] [Related]

  • 17. Double-blind clinical assessment of alprazolam, a new benzodiazepine derivative, in the treatment of moderate to severe anxiety.
    Greiss KC, Fogari R.
    J Clin Pharmacol; 1980 Oct; 20(11):693-9. PubMed ID: 6112245
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ, Wilens TE, Biederman J, Weisler RH, Read SC, Pratt R.
    Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
    [Abstract] [Full Text] [Related]

  • 19. [Alprazolam in the treatment of anxiety disorders and mixed anxiety and depressive disorders. Results of multicenter clinical trial].
    Kiejna A, Małyszczak K, Rzewuska M, Sobucka K, Florkowski A, Rajewski A, Rajewska J, Wojtanowska M, Dabkowski M, Brzeziński R, Rybakowski J, Sep-Kowalikowa B, Gałuszko P, Nowicki Z.
    Psychiatr Pol; 1996 Feb; 30(6):973-92. PubMed ID: 9132771
    [Abstract] [Full Text] [Related]

  • 20. [Efficacy and safety of Aviandr in the treatment of anxiety in patients with adjustment disorders after COVID-19].
    Popova VB, Antonova EA, Hlyabova PM, Rodyukova IS, Alpenidze DN, Drozdova YV, Shamaeva KI, Kryzhanovsky SM, Tarakanova AS, Yakubova EV, Ivaschenko AV, Ivaschenko AA.
    Zh Nevrol Psikhiatr Im S S Korsakova; 2024 Feb; 124(7):131-138. PubMed ID: 39113453
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.